$AGEN
AGENUS INC Stock $agen

$agen Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000156459022007867 Filed on March 01, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$20.26M	$295.7M	$31.27M
YoY Change	-35.2%	235.34%	-9.38%
Cost Of Revenue	$881.0K	$3.470M	$800.0K
YoY Change	10.13%	47.72%
Gross Profit	$19.38M	$292.2M	$30.46M
YoY Change	-36.38%	240.47%
Gross Profit Margin	95.65%	98.83%	97.43%
Selling, General & Admin	$21.97M	$76.36M	$20.03M
YoY Change	9.69%	28.98%	62.58%
% of Gross Profit	113.37%	26.13%	65.76%
Research & Development	$53.49M	$178.6M	$35.57M
YoY Change	50.37%	25.24%	-3.42%
% of Gross Profit	275.99%	61.13%	116.78%
Depreciation & Amortization	$1.655M	$4.600M	$1.840M
YoY Change	-10.05%	-9.8%	10.84%
% of Gross Profit	8.54%	1.57%	6.04%
Operating Expenses	$75.46M	$178.6M	$55.60M
YoY Change	35.71%	25.24%	3.38%
Operating Profit	-$56.08M	$113.6M	-$25.14M
YoY Change	123.06%	-196.89%
Interest Expense	-$14.52M	-$77.20M	-$12.77M
YoY Change	13.72%	26.4%	7.76%
% of Operating Profit		-67.97%
Other Income/Expense, Net	$2.992M	$5.051M	$180.0K
YoY Change	1562.22%	-371.85%	-35.71%
Pretax Income	-$67.61M	-$28.72M	-$37.73M
YoY Change	79.19%	-84.3%	22.3%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$65.51M	-$28.72M	-$37.73M
YoY Change	73.63%	-84.29%	22.3%
Net Earnings / Revenue	-323.34%	-9.72%	-120.68%
Basic Earnings Per Share		-$0.11
Diluted Earnings Per Share	-$255.3K	-$104.5K	-$194.9K
COMMON SHARES
Basic Shares Outstanding		228.9K
Diluted Shares Outstanding		228.9K

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$306.9M	$306.9M	$99.90M
YoY Change	207.23%	207.23%	61.65%
Cash & Equivalents	$291.9M	$291.9M	$99.87M
Short-Term Investments	$14.99M	$14.99M
Other Short-Term Assets	$3.171M	$23.53M	$2.009M
YoY Change	57.84%	85.3%	97.93%
Inventory
Prepaid Expenses	$20.36M		$10.75M
Receivables	$1.518M	$1.518M	$1.157M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$332.0M	$332.0M	$113.8M
YoY Change	191.76%	191.72%	31.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$60.03M	$91.08M	$26.79M
YoY Change	124.07%	51.05%	1.76%
Goodwill	$24.88M		$25.45M
YoY Change	-2.26%		9.76%
Intangibles	$8.488M		$10.89M
YoY Change	-22.03%		3.64%
Long-Term Investments
YoY Change
Other Assets	$9.537M	$9.537M	$4.123M
YoY Change	131.31%	132.61%	190.97%
Total Long-Term Assets	$134.0M	$134.0M	$100.7M
YoY Change	33.01%	33.05%	46.41%
TOTAL ASSETS
Total Short-Term Assets	$332.0M	$332.0M	$113.8M
Total Long-Term Assets	$134.0M	$134.0M	$100.7M
Total Assets	$466.0M	$466.0M	$214.5M
YoY Change	117.22%	117.23%	38.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$30.49M	$30.49M	$17.02M
YoY Change	79.17%	79.33%	25.44%
Accrued Expenses	$42.09M	$44.72M	$29.06M
YoY Change	44.86%	44.25%	-7.26%
Deferred Revenue	$12.43M		$17.19M
YoY Change	-27.7%		-41.09%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$728.0K	$1.063M	$833.0K
YoY Change	-12.61%	-33.56%	28.95%
Total Short-Term Liabilities	$156.9M	$156.9M	$129.9M
YoY Change	20.83%	20.82%	6.28%
LONG-TERM LIABILITIES
Long-Term Debt	$12.82M	$13.14M	$18.88M
YoY Change	-32.08%	-30.47%	41.1%
Other Long-Term Liabilities	$1.577M	$248.0M	$1.514M
YoY Change	4.16%	-0.93%	-63.87%
Total Long-Term Liabilities	$14.40M	$261.1M	$20.39M
YoY Change	-29.39%	-3.01%	16.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$156.9M	$156.9M	$129.9M
Total Long-Term Liabilities	$14.40M	$261.1M	$20.39M
Total Liabilities	$171.3M	$431.5M	$150.3M
YoY Change	14.02%	10.28%	7.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.490B		-$1.466B
YoY Change	1.63%		14.08%
Common Stock	$2.569M		$1.961M
YoY Change	31.0%		42.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$34.44M	$34.44M	-$203.7M
YoY Change
Total Liabilities & Shareholders Equity	$466.0M	$466.0M	$214.5M
YoY Change	117.22%	117.23%	38.1%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$65.51M	-$28.72M	-$37.73M
YoY Change	73.63%	-84.29%	22.3%
Depreciation, Depletion And Amortization	$1.655M	$4.600M	$1.840M
YoY Change	-10.05%	-9.8%	10.84%
Cash From Operating Activities	-$22.93M	$10.15M	-$35.59M
YoY Change	-35.58%	-107.29%	11.99%
INVESTING ACTIVITIES
Capital Expenditures	-$8.962M	$33.81M	-$840.0K
YoY Change	966.9%	875.59%	-20.75%
Acquisitions
YoY Change
Other Investing Activities	-$4.337M	-$9.336M	$0.00
YoY Change		852.65%
Cash From Investing Activities	-$13.30M	-$43.15M	-$830.0K
YoY Change	1502.29%	871.63%	-21.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	71.61M	225.3M	24.65M
YoY Change	190.49%	22.52%	1856.35%
NET CHANGE
Cash From Operating Activities	-22.93M	10.15M	-35.59M
Cash From Investing Activities	-13.30M	-43.15M	-830.0K
Cash From Financing Activities	71.61M	225.3M	24.65M
Net Change In Cash	35.38M	192.1M	-11.77M
YoY Change	-400.59%	372.01%	-62.73%
FREE CASH FLOW
Cash From Operating Activities	-$22.93M	$10.15M	-$35.59M
Capital Expenditures	-$8.962M	$33.81M	-$840.0K
Free Cash Flow	-$13.97M	-$23.67M	-$34.75M
YoY Change	-59.81%	-83.4%	13.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-11481000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6197000
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y2M8D
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	59218000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	178608000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	76359000
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	20362000
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10746000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3171000
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2009000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	331974000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	113783000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2021	dei	Auditor Name AuditorName	KPMG LLP
CY2021	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	291931000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99871000
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	14992000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1518000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1157000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50539000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	47201000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60029000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26790000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	31054000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33480000
CY2021Q4	us-gaap	Goodwill Goodwill	24876000
CY2020Q4	us-gaap	Goodwill Goodwill	25452000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13955000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11841000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8488000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10886000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9537000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4123000
CY2021Q4	us-gaap	Assets Assets	465958000
CY2020Q4	us-gaap	Assets Assets	214514000
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	728000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-117235000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-70137000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28000
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-1221000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1858000
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-41451000
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	833000
CY2021Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Payment Current LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentCurrent	62040000
CY2020Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Payment Current LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentCurrent	57362000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12425000
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	17186000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2627000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1950000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	30486000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17015000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42091000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29057000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6546000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6481000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	156943000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	129884000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12823000
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18879000
CY2021Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Payment Non Current LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentNonCurrent	191708000
CY2020Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Payment Non Current LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentNonCurrent	176263000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	11200000
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	28282000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42109000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34065000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1689000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	10208000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1577000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1514000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	256897910
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	196090980
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2569000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1961000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1520212000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1257502000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1492000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2772000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1489833000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1465907000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	34440000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-203672000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	13469000
CY2020Q4	us-gaap	Minority Interest MinorityInterest	-7826000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47909000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-211498000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	465958000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	214514000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	295665000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88170000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	150048000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	3470000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	2349000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	142617000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	168339000
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46041000
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-5805000
CY2020	agen	Loss On Modification Of Debt LossOnModificationOfDebt	-2720000
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	6197000
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	462000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24137000
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.05
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	228919
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	172504
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	134982
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	4096000
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	215000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	215000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-174545000
CY2019	us-gaap	Profit Loss ProfitLoss	-111560000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	215000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9892000
CY2019	agen	Stock Issued Under Stock Purchase Agreement Value StockIssuedUnderStockPurchaseAgreementValue	30000000
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12962000
CY2019	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	81000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	156421000
CY2020	agen	Stock Issued Under Stock Purchase Agreement Value StockIssuedUnderStockPurchaseAgreementValue	20000000
CY2020	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2374000
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	900000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3145000
CY2020	agen	Payment Of Ceo Payroll In Shares Value PaymentOfCEOPayrollInSharesValue	296000
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	908000
CY2020	agen	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	4469000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-211498000
CY2021	us-gaap	Profit Loss ProfitLoss	-28724000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1280000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19134000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	197648000
CY2021	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	10000000
CY2021	agen	Sale Of Subsidiary Shares In Initial Public Offering SaleOfSubsidiarySharesInInitialPublicOffering	22997000
CY2021	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	70000
CY2021	agen	Payment Of Ceo Payroll In Shares Value PaymentOfCEOPayrollInSharesValue	171000
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	216000
CY2021	agen	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	9132000
CY2021	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1478000
CY2021	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	1648000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47909000
CY2021	us-gaap	Profit Loss ProfitLoss	-28724000
CY2020	us-gaap	Profit Loss ProfitLoss	-182891000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6788000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	9892000
CY2021	agen	Non Cash Royalty And Milestone Revenue NonCashRoyaltyAndMilestoneRevenue	44355000
CY2020	agen	Non Cash Royalty And Milestone Revenue NonCashRoyaltyAndMilestoneRevenue	47545000
CY2019	agen	Non Cash Royalty And Milestone Revenue NonCashRoyaltyAndMilestoneRevenue	30424000
CY2021	agen	Non Cash Interest Expense NonCashInterestExpense	64619000
CY2020	agen	Non Cash Interest Expense NonCashInterestExpense	60029000
CY2019	agen	Non Cash Interest Expense NonCashInterestExpense	42201000
CY2020	agen	Donation Of Assets DonationOfAssets	622000
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3301000
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-198000
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-58000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	11481000
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1221000
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	5805000
CY2020	agen	Loss On Modification Of Debt LossOnModificationOfDebt	-2720000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6197000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	394000
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-11792000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2767000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-234000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-21832000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-11464000
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	53900000
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1062000
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	3826000
CY2019	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	7097000
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-7850000
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2175000
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-1429000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10145000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-139096000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18682000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5656000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33814000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3466000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4657000
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	14992000
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	975000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43150000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4441000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4657000
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	197648000
CY2020	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	176421000
CY2019	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	30000000
CY2021	agen	Proceeds From Sale Of Subsidiary Shares In Initial Public Offering ProceedsFromSaleOfSubsidiarySharesInInitialPublicOffering	22997000
CY2021	agen	Proceeds From Employee Stock Purchases And Option Exercises ProceedsFromEmployeeStockPurchasesAndOptionExercises	9132000
CY2020	agen	Proceeds From Employee Stock Purchases And Option Exercises ProceedsFromEmployeeStockPurchasesAndOptionExercises	4469000
CY2019	agen	Proceeds From Employee Stock Purchases And Option Exercises ProceedsFromEmployeeStockPurchasesAndOptionExercises	1643000
CY2021	agen	Purchase Of Treasury Shares To Satisfy Tax Withholdings PurchaseOfTreasurySharesToSatisfyTaxWithholdings	1654000
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1542000
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	1462000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	855000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1770000
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	320000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	225264000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	183855000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31323000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-164000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	379000
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	770000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	192095000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	40697000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8754000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	102505000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61808000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53054000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	294600000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	102505000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61808000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1152000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1176000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	1224000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5363000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	289000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1242000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020	agen	Business Acquisition Deferred Purchase Price And Contingent Consideration BusinessAcquisitionDeferredPurchasePriceAndContingentConsideration	144000
CY2021	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	10000000
CY2020	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2374000
CY2021	agen	Insurance Financing Agreement InsuranceFinancingAgreement	1630000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1649000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	28184000
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3017000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	762000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	2434000
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	306900000
CY2021	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	207100000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1490000000
CY2021	agen	Number Of Subsidiaries Not Owned NumberOfSubsidiariesNotOwned	2
CY2021	agen	Percentage Of Subsidiaries Not Owned PercentageOfSubsidiariesNotOwned	1
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-top:18pt;margin-bottom:0pt;text-indent:1.7%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">(c) Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.4%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base those estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2021	us-gaap	Depreciation Depreciation	4600000
CY2020	us-gaap	Depreciation Depreciation	5100000
CY2019	us-gaap	Depreciation Depreciation	4800000
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13800000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1000000.0
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3100000
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	100000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020Q4	us-gaap	Goodwill Goodwill	25452000
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-576000
CY2021Q4	us-gaap	Goodwill Goodwill	24876000
CY2021	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	2061000
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	22443000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13955000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8488000
CY2020	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	2132000
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	22727000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11841000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10886000
CY2021	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P9Y
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000.0
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2200000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1700000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	600000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	600000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	600000
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	239900000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2700000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2600000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	291931000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99871000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61808000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2669000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2634000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	294600000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	102505000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61808000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	110568000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	73991000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50539000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	47201000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60029000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26790000
CY2020	agen	Income Tax Reconciliation Foreign Income Inclusion IncomeTaxReconciliationForeignIncomeInclusion	3570000
CY2021Q4	agen	Deferred Tax Assets Operating Loss Carry Forwards Federal And State DeferredTaxAssetsOperatingLossCarryForwardsFederalAndState	171848000
CY2020Q4	agen	Deferred Tax Assets Operating Loss Carry Forwards Federal And State DeferredTaxAssetsOperatingLossCarryForwardsFederalAndState	168786000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	6608000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	5302000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	10577000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	14314000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5383000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4846000
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	33511000
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	39477000
CY2021Q4	agen	Deferred Tax Assets Interest Expense Carryforward DeferredTaxAssetsInterestExpenseCarryforward	11319000
CY2020Q4	agen	Deferred Tax Assets Interest Expense Carryforward DeferredTaxAssetsInterestExpenseCarryforward	7114000
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	51256000
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	58796000
CY2021Q4	agen	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	9945000
CY2020Q4	agen	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	8389000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5285000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4768000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	305732000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	311792000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	297831000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	303747000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7901000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8045000
CY2021Q4	agen	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets Foreign DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssetsForeign	940000
CY2020Q4	agen	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets Foreign DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssetsForeign	1052000
CY2021Q4	agen	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	6946000
CY2020Q4	agen	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	7852000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1017000
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	192000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	8903000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	9096000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1002000
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1051000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5976000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-38706000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23413000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-5916000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	41519000
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7913000
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	1674000
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-764000
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-64000
CY2021	agen	Effective Income Tax Rate Reconciliation Loan Forgiveness EffectiveIncomeTaxRateReconciliationLoanForgiveness	-1301000
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	9242000
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-4675000
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	4144000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2290000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1883000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1367000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-277000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	629000
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-564000
CY2021	agen	Income Tax Reconciliation Income Tax Expense Benefit Change In Fair Value Of Contingent Consideration IncomeTaxReconciliationIncomeTaxExpenseBenefitChangeInFairValueOfContingentConsideration	2343000
CY2020	agen	Income Tax Reconciliation Income Tax Expense Benefit Change In Fair Value Of Contingent Consideration IncomeTaxReconciliationIncomeTaxExpenseBenefitChangeInFairValueOfContingentConsideration	287000
CY2019	agen	Income Tax Reconciliation Income Tax Expense Benefit Change In Fair Value Of Contingent Consideration IncomeTaxReconciliationIncomeTaxExpenseBenefitChangeInFairValueOfContingentConsideration	1219000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2079000
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-3743000
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	9398000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3614000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4292000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4356000
CY2021	agen	Unrecognized Tax Benefits Increase Decrease Related To Current Year Positions UnrecognizedTaxBenefitsIncreaseDecreaseRelatedToCurrentYearPositions	-484000
CY2020	agen	Unrecognized Tax Benefits Increase Decrease Related To Current Year Positions UnrecognizedTaxBenefitsIncreaseDecreaseRelatedToCurrentYearPositions	88000
CY2019	agen	Unrecognized Tax Benefits Increase Decrease Related To Current Year Positions UnrecognizedTaxBenefitsIncreaseDecreaseRelatedToCurrentYearPositions	122000
CY2021	agen	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	18000
CY2020	agen	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	-766000
CY2019	agen	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	-186000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3148000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3614000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4292000
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	14206000
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	7643000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6433000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	32764087
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.70
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	9005010
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.58
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2502716
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.40
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1837019
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.66
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.29
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	868089
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.17
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	32764087
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.66
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6309552
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.49
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4457000
CY2021Q4	agen	Accrued Contract Manufacturing Costs AccruedContractManufacturingCosts	5824000
CY2020Q4	agen	Accrued Contract Manufacturing Costs AccruedContractManufacturingCosts	6274000
CY2021Q4	agen	Accrued Research Services Current AccruedResearchServicesCurrent	8550000
CY2020Q4	agen	Accrued Research Services Current AccruedResearchServicesCurrent	4649000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7078000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6034000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42091000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29057000
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	240000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.66
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.64
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	28966901
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6309552
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	17509054
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.84
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3832406
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.81
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.04
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.77
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4200000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1200000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	385000
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	32000000.0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	886816
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.14
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2025701
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.28
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1826132
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.17
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	68334
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	3.79
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1018051
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.39
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	5800000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	621000
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	357000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	19134000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10121000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9892000
CY2021Q4	agen	Estimate Of Payments For Clinical Trials EstimateOfPaymentsForClinicalTrials	486800000
CY2020	agen	Clinical Trials Expense ClinicalTrialsExpense	64700000
CY2019	agen	Clinical Trials Expense ClinicalTrialsExpense	87700000
CY2021Q4	agen	Cumulative Payments For Clinical Trials CumulativePaymentsForClinicalTrials	372500000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	295665000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88170000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	150048000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	45284000
CY2021	agen	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	761000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	22420000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	23625000
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	0
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	8878000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	4698000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	2551000
CY2021	agen	Finance Lease Cost FinanceLeaseCost	407000
CY2020	agen	Finance Lease Cost FinanceLeaseCost	375000
CY2019	agen	Finance Lease Cost FinanceLeaseCost	221000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	1826000
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	1887000
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	1414000
CY2021	us-gaap	Sublease Income SubleaseIncome	595000
CY2020	us-gaap	Sublease Income SubleaseIncome	578000
CY2019	us-gaap	Sublease Income SubleaseIncome	561000
CY2021	us-gaap	Lease Cost LeaseCost	10516000
CY2020	us-gaap	Lease Cost LeaseCost	6382000
CY2019	us-gaap	Lease Cost LeaseCost	3625000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	2100000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1600000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	1400000
CY2021	agen	Finance Lease Payments FinanceLeasePayments	900000
CY2020	agen	Finance Lease Payments FinanceLeasePayments	1800000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	31054000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33480000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	31054000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33480000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2627000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1950000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42109000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34065000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	44736000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	36015000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2663000
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2231000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2663000
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2231000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	335000
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	746000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	318000
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	66000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	653000
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	812000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7209000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	373000
CY2021Q4	agen	Expected Sublease Receipts Payments To Be Received Due Next Twelve Months ExpectedSubleaseReceiptsPaymentsToBeReceivedDueNextTwelveMonths	613000
CY2021Q4	agen	Net Future Lease Commitments Payments Due Next Twelve Months NetFutureLeaseCommitmentsPaymentsDueNextTwelveMonths	7449000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9568000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	248000
CY2021Q4	agen	Net Future Lease Commitments Payments Due Year Two NetFutureLeaseCommitmentsPaymentsDueYearTwo	9816000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8357000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	88000
CY2021Q4	agen	Net Future Lease Commitments Payments Due Year Three NetFutureLeaseCommitmentsPaymentsDueYearThree	8445000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8544000
CY2021Q4	agen	Net Future Lease Commitments Payments Due Year Four NetFutureLeaseCommitmentsPaymentsDueYearFour	8544000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	8219000
CY2021Q4	agen	Net Future Lease Commitments Payments Due Year Five NetFutureLeaseCommitmentsPaymentsDueYearFive	8219000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	77418000
CY2021Q4	agen	Net Future Lease Commitments Payments Due After Year Five NetFutureLeaseCommitmentsPaymentsDueAfterYearFive	77418000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	104897000
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	709000
CY2021Q4	agen	Expected Sublease Receipts Payments To Be Received ExpectedSubleaseReceiptsPaymentsToBeReceived	613000
CY2021Q4	agen	Net Future Lease Commitments Payments Due NetFutureLeaseCommitmentsPaymentsDue	104993000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	60161000
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	56000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	44736000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	653000
CY2021Q4	agen	Expected Lease Incentives To Be Received Due Next Twelve Months ExpectedLeaseIncentivesToBeReceivedDueNextTwelveMonths	14500000
CY2021Q4	agen	Finance Lease Not Yet Commenced Future Lease Payments FinanceLeaseNotYetCommencedFutureLeasePayments	22400000
CY2021	agen	Finance Lease Not Yet Commenced Expected Commencement Year FinanceLeaseNotYetCommencedExpectedCommencementYear	2022
CY2021Q4	us-gaap	Lessee Finance Lease Lease Not Yet Commenced Term Of Contract1 LesseeFinanceLeaseLeaseNotYetCommencedTermOfContract1	P3Y
CY2021Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Including Unamortized Transaction Costs LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesIncludingUnamortizedTransactionCosts	254105000
CY2021Q4	agen	Liability Related To Sale Of Future Royalties Unamortized Transaction Costs LiabilityRelatedToSaleOfFutureRoyaltiesUnamortizedTransactionCosts	357000
CY2021Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Net LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesNet	253748000
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.116
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.084
CY2021Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	582000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	13551000
CY2020Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	687000
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	19712000
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13800000
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	20000000.0
CY2020Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	675000
CY2020Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.48
CY2020Q1	agen	Price Per Share Premium To Average Closing Price Percentage PricePerSharePremiumToAverageClosingPricePercentage	0.20
CY2020Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Including Unamortized Transaction Costs LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesIncludingUnamortizedTransactionCosts	234041000
CY2021	agen	Non Cash Royalty And Milestone Revenue Recognized NonCashRoyaltyAndMilestoneRevenueRecognized	44355000
CY2021	agen	Non Cash Interest Expense Related To Sale Of Future Royalties NonCashInterestExpenseRelatedToSaleOfFutureRoyalties	64419000
CY2021Q4	agen	Contingent Consideration Liability Fair Value Disclosure ContingentConsiderationLiabilityFairValueDisclosure	1689000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	295665000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88170000
CY2021Q4	us-gaap	Nonfinancial Liabilities Fair Value Disclosure NonfinancialLiabilitiesFairValueDisclosure	1689000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	150048000
CY2020Q4	agen	Contingent Consideration Liability Fair Value Disclosure ContingentConsiderationLiabilityFairValueDisclosure	10208000
CY2020Q4	us-gaap	Nonfinancial Liabilities Fair Value Disclosure NonfinancialLiabilitiesFairValueDisclosure	10208000
CY2021Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13800000
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	20000000.0
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1100000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1100000
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	922000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1100000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1100000
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	922000
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	69566000
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	30913000
CY2021	dei	Auditor Firm AuditorFirmId	185

Files In Submission

Name	View Source	Status
0001564590-22-007867-index-headers.html	Edgar Link	pending
0001564590-22-007867-index.html	Edgar Link	pending
0001564590-22-007867.txt	Edgar Link	pending
0001564590-22-007867-xbrl.zip	Edgar Link	pending
agen-10k_20211231.htm	Edgar Link	pending
agen-10k_20211231_htm.xml	Edgar Link	completed
agen-20211231.xsd	Edgar Link	pending
agen-20211231_cal.xml	Edgar Link	unprocessable
agen-20211231_def.xml	Edgar Link	unprocessable
agen-20211231_lab.xml	Edgar Link	unprocessable
agen-20211231_pre.xml	Edgar Link	unprocessable
agen-ex10102_194.htm	Edgar Link	pending
agen-ex10111_241.htm	Edgar Link	pending
agen-ex10121_239.htm	Edgar Link	pending
agen-ex1012_240.htm	Edgar Link	pending
agen-ex211_8.htm	Edgar Link	pending
agen-ex231_10.htm	Edgar Link	pending
agen-ex311_7.htm	Edgar Link	pending
agen-ex312_9.htm	Edgar Link	pending
agen-ex321_6.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gdt0xxrtlhex000001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AGEN
AGENUS INC Stock $agen

2021 Q4 Form 10-K Financial Statement

#000156459022007867 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGEN AGENUS INC Stock $agen

2021 Q4 Form 10-K Financial Statement

#000156459022007867 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGEN
AGENUS INC Stock $agen